Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -20.13%. However, over the past six months, we’ve seen a stronger performance of -22.82%. The price of CLDX leaped by -15.98% over the last 30 days. And in the last five days, it has fallen by -24.31%.
Celldex Therapeutics Inc. had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $53.18 on 03/04/24, while the lowest price during the same period was $22.11 on 10/30/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of CLDX Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Celldex Therapeutics Inc.’s current trading price is -40.44% away from its 52-week high, while its distance from the 52-week low is 43.26%. The stock’s price range over this timeframe has been between $22.11 and $53.18. The shares of the Healthcare sector company recorded a trading volume of approximately 4.53 million for the day, which was comparatively higher than the average daily volume of 0.73 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Celldex Therapeutics Inc. (CLDX) has experienced a quarterly decline of -12.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.10B and boasts a workforce of 160 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 37.75, with a change in price of -8.52. Similarly, Celldex Therapeutics Inc. recorded 708,843 in trading volume during the last 100 days, posting a change of -20.85%.
CLDX’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CLDX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
CLDX Stock Stochastic Average
The raw stochastic average for Celldex Therapeutics Inc. over the last 50 days is presently at 6.03%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 0.00%. Further, the company’s Stochastic %K and %D values for the last 20 days were 49.65% and 50.81%, respectively.
